Reuters logo
Stada sees 2013 EBITDA up 18 pct on 10 pct higher sales
March 3, 2014 / 1:15 PM / in 4 years

Stada sees 2013 EBITDA up 18 pct on 10 pct higher sales

FRANKFURT, March 3 (Reuters) - German generic drugmaker Stada Arzneimittel said on Monday it expected its 2013 underlying profit has risen by 18 percent on the back of a 10 percent sales increase.

It said reported earnings before interest, tax, depreciation and amortization (EBITDA) was expected to have increased to 383.5 million euros ($529.67 million), with sales rising to 2.0 billion euros.

Stada proposed to pay a dividend of 0.66 euros per share compared with 0.50 euros for the previous year. ($1 = 0.7240 euros) (Reporting by Marilyn Gerlach; Editing by Harro ten Wolde)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below